Evaluating the impact of cenobamate in the management in patients with drug resistant focal epilepsy – A retrospective real world observational study of patients attending NHS Greater Glasgow and Clyde
These results offer insights for clinicians regarding the real-world effectiveness, retention rates, and healthcare cost implications of CNB therapy in a cohort consisting largely of patients with severe drug resistant epilepsy. Further studies are ongoing to assess the efficacy of CNB when used earlier and also to provide a comprehensive assessment of health care resource use in this real world settings.
Authors
- Steven Yule (ORCID: https://orcid.org/0000-0001-9889-9090)
- Craig A. Heath (ORCID: https://orcid.org/0000-0002-1228-3357)
- Seán MacBride‐Stewart (ORCID: https://orcid.org/0000-0002-2553-5939)
- Linda J. Stephen (ORCID: https://orcid.org/0000-0002-9279-0665)
- AD Marshall (ORCID: https://orcid.org/0000-0002-9461-5836)
- Moutaz Taha (ORCID: https://orcid.org/0000-0002-8805-7006)
- Stuart T. Nichol
Institutions
- NHS Greater Glasgow and Clyde (GB)
- University of Glasgow (GB)
Publication Details
- Journal
- Epilepsy Research
- Published
- 2025-12-02
- DOI
- https://doi.org/10.1016/j.eplepsyres.2025.107717
- Primary Topic
- Epilepsy research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00